Cardio-oncology : management of toxicities in the era of immunotherapy / Antonio Russo, Nicola Maurea, Dimitrios Farmakis, Antonio Giordano, editors.
2022
RC271.I45 C27 2022eb
Linked e-resources
Linked Resource
Online Access
Concurrent users
Unlimited
Authorized users
Authorized users
Document Delivery Supplied
Can lend chapters, not whole ebooks
Details
Title
Cardio-oncology : management of toxicities in the era of immunotherapy / Antonio Russo, Nicola Maurea, Dimitrios Farmakis, Antonio Giordano, editors.
ISBN
9783030977443 (electronic bk.)
3030977447 (electronic bk.)
9783030977436
3030977439
3030977447 (electronic bk.)
9783030977436
3030977439
Published
Cham : Humana Press, [2022]
Copyright
©2022
Language
English
Description
1 online resource (xiv, 122 pages : illustrations (some color)).
Other Standard Identifiers
10.1007/978-3-030-97744-3 doi
Call Number
RC271.I45 C27 2022eb
Dewey Decimal Classification
616.99/4061
Summary
The development of immunotherapy in oncology field has revolutionized the prognosis of many types of cancer. The immune checkpoint inhibitors target receptors whose inhibition increases the activity of immune system cells against tumor cells. In recent years, new immunotherapies have been studied and approved in a growing number of tumors including melanoma, non-small cell lung cancer (NSCLC), and renal cell cancer (RCC). This volume provides a complete and updated state-of-art review regarding the management of cardiovascular toxicities from new immunotherapies. The manuscript is divided into different sections starting from the relationship between cancer and immune system to let the reader understand the new molecular concepts under immunotherapy development. Subsequent chapters describe specifically the immunotherapy options in solid tumor treatment and the main features of the immuno-related cardiovascular complications. This volume is written by experts in the oncological and cardiovascular fields and aims to provide to clinicians who approach current cancer patients a useful tool to move through the paths of modern cardio-oncology. An important section would afford the most relevant interventions needed to manage the cardiac events, suggesting how to reduce their impact and effects on oncological outcomes. The text concludes by addressing future perspectives in the cardio-immunology field, discussing many aspects such as the early detection of cardiovascular damage and the potential role of liquid biopsy in new damage-related biomarkers discovery.
Note
Includes index.
Access Note
Access limited to authorized users.
Source of Description
Online resource; title from PDF title page (SpringerLink, viewed August 19, 2022).
Added Author
Russo, Antonio, 1956- editor.
Maurea, Nicola, editor.
Farmakis, Dimitrios, editor.
Giordano, Antonio, MD, editor.
Maurea, Nicola, editor.
Farmakis, Dimitrios, editor.
Giordano, Antonio, MD, editor.
Series
Current clinical pathology.
Available in Other Form
Print version: 9783030977436
Linked Resources
Online Access
Record Appears in
Online Resources > Ebooks
All Resources
All Resources
Table of Contents
Background: Immunology and Cancer
Available Immunotherapy Drugs in Oncology
Immunotherapy Adverse Events
Pathophysiology of Cardiac Toxicity
Diagnostic Methods of Cardiac Immunotherapy Damaging
Biomarkers of Early Cardiotoxicity
Management of Patients with Cardiac Toxicity: The Point of View of the Cardiologist
Management of Patients with Cardiac Toxicity: The Point of View of the Oncologist
Future perspectives.
Available Immunotherapy Drugs in Oncology
Immunotherapy Adverse Events
Pathophysiology of Cardiac Toxicity
Diagnostic Methods of Cardiac Immunotherapy Damaging
Biomarkers of Early Cardiotoxicity
Management of Patients with Cardiac Toxicity: The Point of View of the Cardiologist
Management of Patients with Cardiac Toxicity: The Point of View of the Oncologist
Future perspectives.